STS and cancer: Compounds of type 3a-3e were early used for the treatment of hormone-dependent breast cancer since they lead to a reduction of estrogenic steroids, responsible for the growth and development of this type of cancer, via the steroid sulfatase (STS) pathway (Reed et al., 2005; Stanway et al., 2006; Woo et al., 2008).